All Articles

Soccer icon Dwayne De Rosario partners with tech platform LINKSPORTS, aiming to dismantle the financial barriers that sideline one in three Canadian kids.

MetTel's recent Gartner recognition is more than an accolade; it's a signpost for the future of work where AI and automation manage our corporate devices.

With a potential $4 billion on the line, CytomX and Regeneron are building a new class of cancer therapies designed to act like autonomous agents in the body.

New long-term data for UPLIZNA and TAVNEOS show sustained disease control and reduced steroid use, offering a tangible difference for rare disease patients.

With its massive Resulticks acquisition delayed again, London's Diginex tests investor faith, betting its future on an audacious ethics-meets-commerce vision.

The new INYY ETF promises massive income from Intel's volatility. But a look under the hood reveals NAV erosion, capped gains, and a return of your own capital.

A new free tool promises to arm security providers with an attacker's-eye view, but its real impact may be in reshaping the competitive landscape.

Vanessa Fusco's win as top female roofer isn't just a personal victory. It signals a major shift in a male-dominated industry and a new model for social impact.

TPH Academy's new Chief Growth Officer isn't just a new hire; he's a signal of intent. Steve Sanders brings a playbook for scaling that could reshape the market.

LA's cultural phenomenon Happy Ice expands to Downtown Disney, debuting an all-natural menu and innovative desserts. Founder Lemeir Mitchell's journey comes full circle.

As Prime Medicine prepares for a key investor conference, its next-gen 'search and replace' gene editing technology faces a crucial test. Can it deliver on its promise?

For decades, businesses have relied on robust IBM i systems. But what happens when they fail? A new AI-driven approach aims to prevent catastrophe, not just clean it up.

As autonomous AI enters healthcare, Datavant joins a key consortium to build the safety guardrails, ensuring patient trust and data integrity remain paramount.

A new AI agent from AlphaSense promises to do more than just find data—it executes complex tasks. We look at the tech, trust, and future of work.

As enterprises grapple with soaring AI expenses, the Linux Foundation is launching the Tokenomics Foundation to bring financial discipline to the AI frontier.

A new $515M contract for the SPY-6 radar is more than a sale; it's a strategic play cementing U.S. tech dominance and revitalizing domestic manufacturing.

A new AI can detect Parkinson's progression where the current gold standard fails. In a stunning validation, the study was led by the very scientists who created the old method.

Cemvita's breakthrough 75,000-liter scale-up turns biodiesel waste into renewable oil, paving the way for a new generation of Sustainable Aviation Fuel.

Crescent's largest-ever fund close highlights booming investor appetite for private credit and promises a major capital infusion for the U.S. lower middle market.

Top 20 firm Cherry Bekaert partners with Fieldguide for a massive agentic AI deployment, signaling a major industry shift from point tools to AI-native platforms.